The U.S.-funded Blue Star factory in Virginia, meant to boost domestic production of nitrile gloves after COVID-19, is on the verge of being sold for parts after running out of money despite receiving $123 million in federal support. The broader $850 million government effort to revive U.S. glove manufacturing has largely failed, with none of the funded companies producing gloves and the country still heavily dependent on imports, mainly from Malaysia and raw materials from China. Rising construction costs, expensive domestic production compared to cheaper imports, and supply chain challenges made the project unviable. As a result, the unfinished plant never created the expected 2,500 jobs and highlights ongoing U.S. vulnerability in critical medical supply manufacturing.
WAGRAMWAGRAM on
What will the US do without this essential technology in case of a war?
I know, what to do, 150% tariffs on Malaysian synthetic polymers!
2 Comments
Submission statement:
The U.S.-funded Blue Star factory in Virginia, meant to boost domestic production of nitrile gloves after COVID-19, is on the verge of being sold for parts after running out of money despite receiving $123 million in federal support. The broader $850 million government effort to revive U.S. glove manufacturing has largely failed, with none of the funded companies producing gloves and the country still heavily dependent on imports, mainly from Malaysia and raw materials from China. Rising construction costs, expensive domestic production compared to cheaper imports, and supply chain challenges made the project unviable. As a result, the unfinished plant never created the expected 2,500 jobs and highlights ongoing U.S. vulnerability in critical medical supply manufacturing.
What will the US do without this essential technology in case of a war?
I know, what to do, 150% tariffs on Malaysian synthetic polymers!